What is United States Antimony's operating income?

United States Antimony's total operating income in 2025 was -$8.46 million, based on the following breakdown: Total Gross Profit: $9.87 million Total Operating Expenses: $18.33 million

United States Antimony (UAMY) Financials

$3.12 -0.09 (-2.65%)

Closing price 11/11/2026 03:59 PM Eastern

Extended Trading

$3.18 +0.06 (+1.92%)

As of 05:05 AM Eastern

Compare

Annual Income Statements for United States Antimony

This table shows United States Antimony's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-0.89	-1.36	-1.18	0.82	-3.72	-3.34	-0.11	0.38	-6.36	-1.74	-4.35
Consolidated Net Income / (Loss)	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Net Income / (Loss) Continuing Operations	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Total Pre-Tax Income	-0.84	-1.01	-1.13	0.54	-3.67	-3.29	-0.06	0.44	-6.35	-1.73	-4.34
Total Operating Income	-0.81	-0.82	-0.96	0.55	-3.75	-3.30	-0.66	0.35	-7.07	-2.39	-8.46
Total Gross Profit	-0.41	0.54	0.28	0.00	-0.82	0.21	0.84	2.00	-3.34	3.47	9.87
Total Revenue	13	12	10	9.03	8.27	5.24	7.75	11	8.69	15	39
Operating Revenue	13	12	10	9.03	8.27	5.24	7.75	11	8.69	15	39
Total Cost of Revenue	14	11	9.95	9.03	9.08	5.03	6.91	9.05	12	11	29
Operating Cost of Revenue	14	11	9.95	9.03	9.08	5.03	6.91	9.05	12	11	29
Total Operating Expenses	0.40	1.35	1.24	-0.55	2.94	3.51	1.50	1.65	3.72	5.86	18
Selling, General & Admin Expense	1.02	0.99	0.86	1.28	1.01	1.54	1.24	1.17	3.51	5.85	19
Other Operating Expenses / (Income)	-0.62	0.36	0.37	-1.82	0.52	1.49	0.07	0.48	-	0.00	-0.47
Other Special Charges / (Income)	-	-	-	0.00	1.41	0.32	-	0.00	0.22	0.01	0.05
Total Other Income / (Expense), net	-0.03	-0.19	-0.17	-0.01	0.08	0.02	0.60	0.10	0.72	0.66	4.12
Interest & Investment Income	0.01	0.00	0.00	-	-	-	0.05	0.10	0.62	0.67	0.81
Other Income / (Expense), net	-0.04	-0.04	-0.07	0.09	0.16	0.04	0.44	-0.01	0.10	-0.01	3.31
Income Tax Expense	0.00	0.30	0.00	-0.33	-	-	0.00	0.02	0.00	0.00	0.00
Preferred Stock Dividends Declared	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	-0.01	0.01	0.01
Basic Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	-	$0.00	($0.06)	($0.02)	($0.04)
Weighted Average Basic Shares Outstanding	66.21M	66.78M	67.41M	67.98M	69.00M	72.51M	102.84M	106.29M	107.55M	108.59M	123.64M
Diluted Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	-	$0.00	($0.06)	($0.02)	($0.04)
Weighted Average Diluted Shares Outstanding	66.21M	66.78M	67.41M	68.10M	69.00M	72.51M	102.84M	106.29M	107.55M	108.59M	123.64M
Weighted Average Basic & Diluted Shares Outstanding	66.21M	66.78M	59.20M	82.50M	69.00M	72.51M	102.84M	-	-	114.63M	143.37M

This table shows United States Antimony's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	-3.56	-0.32	0.20	-0.73	-0.88	0.54	0.18	-4.78	-0.29	-11	0.11
Consolidated Net Income / (Loss)	-3.56	-0.32	0.20	-0.73	-0.88	0.55	0.18	-4.78	-0.29	-11	0.11
Net Income / (Loss) Continuing Operations	-6.43	-0.32	0.20	-0.73	-1.08	0.55	0.18	-4.78	-0.29	-11	0.11
Total Pre-Tax Income	-5.04	-0.32	0.20	-0.73	-0.67	0.55	0.18	-4.78	-0.29	-11	0.17
Total Operating Income	-6.88	-0.47	0.06	-0.89	-1.26	0.36	0.02	-4.92	-3.92	-7.52	-6.98
Total Gross Profit	-4.38	0.59	1.25	0.42	1.31	2.37	2.84	2.01	2.65	1.11	0.58
Total Revenue	2.15	3.07	3.66	2.57	6.87	7.00	11	8.70	13	6.78	7.93
Operating Revenue	2.15	3.07	3.66	2.57	6.87	7.00	11	8.70	13	6.78	7.93
Total Cost of Revenue	6.54	2.48	2.41	2.15	5.56	4.63	7.69	6.69	10	5.67	7.34
Operating Cost of Revenue	6.54	2.48	2.41	2.15	5.56	4.63	7.69	6.69	10	5.67	7.34
Total Operating Expenses	0.79	1.06	1.19	1.31	2.61	2.01	2.82	6.93	6.57	8.63	7.56
Selling, General & Admin Expense	2.26	1.04	1.19	1.33	3.09	1.01	1.45	7.41	6.51	2.75	3.34
Other Operating Expenses / (Income)	-	-	-	0.00	-	1.00	1.36	-0.47	-	5.88	4.22
Other Special Charges / (Income)	0.22	0.02	0.00	-0.02	0.04	-0.00	0.00	-0.01	0.06	-0.00	0.00
Total Other Income / (Expense), net	-0.05	0.15	0.15	0.16	0.19	0.19	0.16	0.14	3.63	-3.76	7.15
Interest & Investment Income	0.15	0.15	0.15	0.16	0.21	0.19	0.15	0.15	0.31	0.33	0.43
Other Income / (Expense), net	-0.20	-0.00	-0.01	0.01	-0.02	-0.00	0.01	-0.01	3.32	-4.09	6.72
Income Tax Expense	-	0.00	0.00	0.00	-	-	0.00	0.00	-	-	0.00
Other Gains / (Losses), net	-	-	-	-	-	0.00	0.00	-	-	-0.02	-0.06
Preferred Stock Dividends Declared	-	0.00	0.00	0.00	-0.01	0.00	0.00	0.00	0.00	0.00	0.00
Basic Earnings per Share	($322,555,106.06)	$0.00	$0.00	($0.01)	($324,786,274.02)	$0.00	$0.00	($0.04)	-	($0.08)	$0.00
Weighted Average Basic Shares Outstanding	107.55M	107.91M	108.44M	108.44M	108.59M	113.70M	118.26M	123.41M	123.64M	141.61M	146.61M
Diluted Earnings per Share	($322,555,106.06)	$0.00	$0.00	($0.01)	($325,290,416.02)	$0.00	$0.00	($0.04)	-	($0.08)	$0.00
Weighted Average Diluted Shares Outstanding	107.55M	107.91M	108.94M	108.44M	108.59M	122.39M	127.22M	123.41M	123.64M	141.61M	151.75M
Weighted Average Basic & Diluted Shares Outstanding	0.00	108.44M	108.44M	108.44M	114.63M	117.92M	120.72M	140.04M	143.37M	148.19M	149.67M

This table details how cash moves in and out of United States Antimony's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	0.01	-0.12	0.02	0.02	0.06	0.55	24	-2.30	-7.64	6.32	12
Net Cash From Operating Activities	0.36	0.43	0.72	-0.66	-0.01	-1.31	-2.43	-0.25	-4.75	2.22	-9.69
Net Cash From Continuing Operating Activities	-0.06	0.38	0.54	-0.66	-0.01	-1.31	0.72	2.32	-5.23	2.24	-9.69
Net Income / (Loss) Continuing Operations	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Consolidated Net Income / (Loss)	-0.84	-1.31	-1.13	0.87	-3.67	-3.29	-0.06	0.43	-6.35	-1.73	-4.34
Depreciation Expense	0.93	1.00	0.97	0.90	0.90	0.89	0.88	0.91	0.96	1.09	1.17
Non-Cash Adjustments To Reconcile Net Income	0.07	0.11	0.21	-1.95	1.70	0.43	0.43	0.36	2.41	0.63	4.20
Changes in Operating Assets and Liabilities, net	0.19	0.56	0.58	-0.56	1.01	0.66	-0.53	0.62	-2.25	2.26	-11
Net Cash From Investing Activities	-1.70	-0.58	-0.37	0.90	-0.39	-0.24	-0.65	-1.79	-1.34	-0.04	-87
Net Cash From Continuing Investing Activities	-1.70	-0.58	-0.37	0.90	-0.39	-0.24	-0.65	-1.79	-1.34	-0.04	-87
Purchase of Property, Plant & Equipment	-1.71	-0.60	-0.37	-0.90	-0.79	-0.24	-0.65	-1.73	-1.53	-0.43	-28
Purchase of Investments	-	-	-	-	-	-	0.00	-16	-	0.00	-57
Sale of Property, Plant & Equipment	0.01	-	0.00	0.30	0.40	-	-	-	0.00	0.32	0.01
Other Investing Activities, net	0.00	0.01	-	-	-	0.00	-0.00	-	0.19	0.00	-2.50
Net Cash From Financing Activities	1.36	0.03	-0.33	-0.22	0.46	2.10	24	-0.27	-1.07	4.14	109
Net Cash From Continuing Financing Activities	1.36	0.03	-0.33	-0.22	0.46	2.10	24	-0.27	-1.07	4.14	109
Repayment of Debt	-0.09	-0.18	-0.21	-0.38	-0.16	-0.23	-0.14	-0.06	-0.28	-0.10	-0.13
Repurchase of Common Equity	-	-	-	-	-	-	0.00	-0.20	-	0.00	-0.45
Issuance of Common Equity	-	-	-	0.00	0.40	1.81	23	-	0.00	-	104
Other Financing Activities, net	1.32	0.17	-0.15	0.02	-0.03	0.07	0.58	-	-	1.48	5.85
Cash Interest Paid	-	0.01	0.01	0.02	0.02	0.02	0.01	0.02	0.01	0.01	0.02

This table details how cash moves in and out of United States Antimony's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	1.44	-0.64	1.13	0.62	5.88	0.57	-13	13	12	-27	39
Net Cash From Operating Activities	-4.05	0.07	0.57	0.41	1.34	-1.73	-0.63	-3.86	-3.47	-12	-8.66
Net Cash From Continuing Operating Activities	-4.53	-0.61	1.25	0.42	1.86	-1.73	-0.63	-3.86	-3.47	-12	-8.66
Net Income / (Loss) Continuing Operations	-6.43	0.00	-0.12	-0.73	-1.08	0.55	0.18	-4.78	-0.29	-11	0.11
Consolidated Net Income / (Loss)	-6.43	-	-	-0.73	-	0.55	0.18	-4.78	-0.29	-11	0.11
Depreciation Expense	0.71	0.11	0.11	0.12	0.75	0.28	0.28	0.28	0.33	0.41	0.52
Non-Cash Adjustments To Reconcile Net Income	2.38	0.14	0.19	0.21	0.64	0.41	0.61	3.32	-0.14	8.87	-4.07
Changes in Operating Assets and Liabilities, net	-1.19	-0.86	1.06	0.81	1.55	-2.97	-1.70	-2.68	-3.37	-10	-5.22
Net Cash From Investing Activities	-0.00	-0.00	-0.10	0.24	-0.18	-0.86	-17	-19	-51	-13	1.46
Net Cash From Continuing Investing Activities	-0.00	-0.00	-0.10	0.24	-0.18	-0.86	-17	-19	-51	-13	1.46
Purchase of Property, Plant & Equipment	-0.19	-0.05	-0.10	-0.07	-0.21	-0.86	-6.53	-8.68	-12	-13	-10
Acquisitions	-	-	-	-	-	0.00	-	-	-	-0.10	-0.05
Purchase of Investments	-	-	-	-	-	0.00	-	-9.94	-37	0.00	-1.29
Sale and/or Maturity of Investments	-	-	-	-	-	0.00	-	-	-	0.10	1.30
Net Cash From Financing Activities	-0.21	-0.02	-0.02	-0.03	4.21	3.17	4.11	35	67	-2.63	46
Net Cash From Continuing Financing Activities	-0.21	-0.02	-0.02	-0.03	4.21	3.17	4.11	35	67	-2.63	46
Repayment of Debt	-0.21	-0.02	-0.02	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.03	-0.04
Repurchase of Common Equity	-	-	-	-	-	0.00	-	-	-0.04	-4.98	-2.80
Issuance of Debt	-	-	-	-	-	2.39	2.67	33	-	1.34	48
Other Financing Activities, net	-	-	-	-	-	0.81	-	4.43	1.37	1.04	1.18
Cash Interest Paid	-	0.00	0.00	0.00	-	0.00	0.00	0.01	0.00	0.00	0.06

This table presents United States Antimony's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	18	18	17	18	14	13	35	35	28	35	154
Total Current Assets	2.14	1.69	1.56	1.90	1.28	1.81	24	22	14	21	55
Cash & Equivalents	0.13	0.01	0.03	0.06	0.12	0.67	21	19	12	18	30
Short-Term Investments	0.25	0.25	0.25	0.25	0.25	0.25	0.26	0.26	0.07	0.00	4.58
Note & Lease Receivable	-	-	-	-	-	-	-	-	-	0.00	2.50
Accounts Receivable	0.42	0.55	0.36	0.44	0.28	0.24	0.89	0.78	0.63	1.10	4.21
Inventories, net	1.09	0.86	0.91	0.76	0.63	0.65	1.06	1.38	1.39	1.25	13
Prepaid Expenses	-	-	-	-	-	-	0.00	0.14	0.09	0.16	0.43
Plant, Property, & Equipment, net	16	16	15	15	12	11	11	12	13	13	42
Total Noncurrent Assets	0.09	0.38	0.44	0.43	0.23	0.27	0.30	0.95	0.56	1.07	57
Long-Term Investments	0.08	0.06	0.06	0.06	0.06	0.06	-	-	-	0.00	56
Other Noncurrent Operating Assets	0.02	0.31	0.37	0.37	0.17	0.21	0.30	0.95	0.56	0.97	0.38
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	0.10	0.16
Total Liabilities & Shareholders' Equity	18	18	17	18	14	13	35	35	28	35	154
Total Liabilities	5.80	6.42	6.75	6.13	5.23	6.11	2.63	2.83	2.57	6.04	13
Total Current Liabilities	2.43	3.38	3.93	3.52	3.98	4.48	2.07	2.22	0.90	4.01	10
Short-Term Debt	0.31	0.56	0.74	0.89	0.25	0.15	0.01	0.09	0.03	0.13	0.14
Accounts Payable	1.66	1.81	2.30	2.02	2.69	2.10	1.44	0.63	0.46	1.55	6.92
Accrued Expenses	0.14	0.12	0.17	0.35	0.64	0.64	0.27	0.71	0.41	1.60	3.08
Other Current Liabilities	0.01	0.19	0.04	0.06	0.40	0.46	0.35	-	0.00	0.63	0.03
Total Noncurrent Liabilities	3.37	3.04	2.82	2.61	1.25	1.64	0.56	0.61	1.68	2.04	2.79
Long-Term Debt	1.72	1.47	1.24	1.03	0.08	0.48	0.20	0.22	0.00	0.20	0.06
Asset Retirement Reserve & Litigation Obligation	-	-	-	-	-	-	0.30	0.33	1.64	1.71	2.72
Other Noncurrent Operating Liabilities	1.65	1.57	1.58	1.59	1.17	1.16	0.06	0.06	0.04	0.13	0.01
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	-	-	-	-	0.00	0.00
Total Equity & Noncontrolling Interests	12	11	10	11	8.47	7.19	32	32	26	29	141
Total Preferred & Common Equity	12	11	10	11	8.47	7.19	32	32	26	29	141
Preferred Stock	0.00	0.00	0.00	0.03	0.03	0.03	0.03	0.03	0.01	0.01	0.01
Total Common Equity	12	11	10	11	8.44	7.16	32	32	26	29	141
Common Stock	37	37	37	37	38	40	65	65	65	70	187
Retained Earnings	-24	-25	-27	-26	-29	-33	-33	-33	-39	-41	-45
Treasury Stock	-	-	-	-	-	-	0.00	-0.20	-	0.00	-0.57

This table presents United States Antimony's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026	6/30/2026
Total Assets	32	31	28	29	30	39	47	80	148	191
Total Current Assets	18	17	14	15	15	25	18	32	48	77
Cash & Equivalents	14	13	12	12	13	19	5.71	18	3.22	41
Short-Term Investments	0.26	0.26	0.02	0.02	0.02	-	1.26	1.27	4.62	4.67
Note & Lease Receivable	-	-	-	-	-	-	-	-	2.45	4.00
Accounts Receivable	1.31	1.39	1.06	1.39	0.79	1.97	2.54	1.90	2.51	2.61
Inventories, net	2.35	1.88	0.65	0.46	0.97	3.99	6.81	8.41	22	22
Prepaid Expenses	0.38	0.24	0.12	0.29	0.18	0.13	1.35	1.88	0.73	2.31
Plant, Property, & Equipment, net	13	13	7.71	7.80	7.75	13	20	28	47	53
Total Noncurrent Assets	1.22	1.31	6.29	6.52	7.00	1.09	10	20	53	61
Long-Term Investments	-	-	-	-	-	-	8.83	19	52	59
Other Noncurrent Operating Assets	1.22	1.31	0.07	6.52	0.88	1.09	1.27	0.94	0.37	0.36
Other Noncurrent Nonoperating Assets	-	-	6.22	-	6.12	-	-	-	0.16	0.82
Total Liabilities & Shareholders' Equity	32	31	28	29	30	39	47	80	148	191
Total Liabilities	1.54	1.85	2.60	3.23	4.63	6.91	9.99	8.13	16	9.59
Total Current Liabilities	0.98	1.28	0.91	1.25	2.40	4.72	8.00	6.26	13	6.64
Short-Term Debt	0.08	0.06	0.01	0.13	0.13	0.13	0.13	0.14	0.14	0.18
Accounts Payable	0.41	0.61	0.40	0.54	1.21	3.21	5.75	4.22	9.67	3.94
Accrued Expenses	0.27	0.33	0.34	0.43	0.43	0.80	1.52	1.79	3.53	2.51
Other Current Liabilities	0.22	0.28	-	-	0.48	0.58	0.59	0.12	0.03	0.02
Total Noncurrent Liabilities	0.57	0.57	1.69	1.98	2.22	2.19	2.00	1.87	2.79	2.95
Long-Term Debt	0.18	0.18	-	0.26	0.23	0.16	0.13	0.09	0.02	0.16
Asset Retirement Reserve & Litigation Obligation	0.34	0.34	1.12	1.14	1.16	1.73	1.75	1.77	2.75	2.79
Other Noncurrent Operating Liabilities	0.04	0.04	0.04	0.04	0.30	0.29	0.12	0.01	0.01	0.01
Commitments & Contingencies	-	-	-	-	-	-	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	31	29	25	26	25	33	38	72	132	181
Total Preferred & Common Equity	31	29	25	26	25	33	38	72	132	181
Preferred Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Total Common Equity	31	29	25	26	25	33	37	72	132	181
Common Stock	65	65	65	65	65	73	78	117	195	247
Retained Earnings	-34	-36	-40	-40	-40	-41	-40	-45	-57	-57
Treasury Stock	0.00	0.00	-	-	-	-	-	-0.51	-6.37	-9.42

This table displays calculated financial ratios and metrics derived from United States Antimony's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	66,316,278.00	66,866,278.00	67,488,153.00	68,227,171.00	69,661,436.00	75,949,757.00	106,117,844.00	106,373,341.00	107,647,317.00	-	140,035,604.00
DEI Adjusted Shares Outstanding	66,316,278.00	66,866,278.00	67,488,153.00	68,227,171.00	69,661,436.00	75,949,757.00	106,117,844.00	106,373,341.00	107,647,317.00	-	140,035,604.00
DEI Earnings Per Adjusted Shares Outstanding	-0.01	-0.02	-0.02	0.01	-0.05	-0.04	0.00	0.00	-0.06	-	-0.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-0.57	-0.57	-0.67	0.88	-2.63	-2.31	-0.46	0.34	-4.95	-1.67	-5.92
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-19.37%	-5.79%	-4.20%
Earnings before Interest and Taxes (EBIT)	-0.84	-0.85	-1.03	0.64	-3.59	-3.27	-0.22	0.34	-6.97	-2.40	-5.15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.09	0.22	0.03	1.63	-2.64	-2.38	0.66	1.25	-6.01	-1.31	-3.98
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-1.17	0.41	0.37	-0.08	1.98	-0.78	-4.58	-2.35	-4.88	1.25	-45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	14	13	12	13	8.37	6.84	11	14	14	11	50
Increase / (Decrease) in Invested Capital	0.61	-0.98	-1.04	0.96	-4.60	-1.53	4.12	2.69	-0.07	-2.92	39
Book Value per Share	$0.19	$0.17	$0.15	$0.17	$0.12	$0.09	$0.30	$0.30	$0.24	$0.26	$1.01
Tangible Book Value per Share	$0.19	$0.17	$0.15	$0.17	$0.12	$0.09	$0.30	$0.30	$0.24	$0.26	$1.01
Total Capital	14	13	12	13	8.80	7.82	33	32	26	29	141
Total Debt	2.03	2.03	1.98	1.92	0.33	0.63	0.22	0.31	0.03	0.33	0.20
Total Long-Term Debt	1.72	1.47	1.24	1.03	0.08	0.48	0.20	0.22	0.00	0.20	0.06
Net Debt	1.57	1.71	1.64	1.55	-0.10	-0.35	-21	-19	-12	-18	-91
Capital Expenditures (CapEx)	1.70	0.60	0.37	0.60	0.39	0.24	0.65	1.73	1.53	0.11	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.37	-1.39	-1.91	-1.03	-2.81	-3.44	-0.11	0.17	1.23	-1.47	9.63
Debt-free Net Working Capital (DFNWC)	0.02	-1.13	-1.63	-0.72	-2.44	-2.52	22	19	13	17	45
Net Working Capital (NWC)	-0.29	-1.69	-2.37	-1.61	-2.70	-2.67	21	19	13	17	45
Net Nonoperating Expense (NNE)	0.27	0.74	0.46	0.01	1.05	0.97	-0.40	-0.09	1.40	0.06	-1.58
Net Nonoperating Obligations (NNO)	1.57	1.71	1.64	1.55	-0.10	-0.35	-21	-18	-12	-18	-91
Total Depreciation and Amortization (D&A)	0.93	1.07	1.06	0.99	0.95	0.89	0.88	0.91	0.96	1.09	1.17
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	$0.00	$0.00	($0.06)	($0.02)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	66.32M	67.49M	59.20M	67.98M	69.00M	102.80M	106.24M	106.29M	107.55M	108.59M	123.64M
Adjusted Diluted Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	$0.00	$0.00	($0.06)	($0.02)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	66.32M	67.49M	59.20M	68.10M	69.00M	102.80M	106.24M	106.29M	107.55M	108.59M	123.64M
Adjusted Basic & Diluted Earnings per Share	($0.01)	($0.02)	($0.02)	$0.01	($0.05)	($0.05)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.21M	66.78M	67.41M	82.50M	69.00M	72.51M	102.84M	0.00	0.00	114.63M	143.37M
Normalized Net Operating Profit after Tax (NOPAT)	-0.57	-0.57	-0.67	0.38	-1.64	-2.09	-0.46	0.34	-4.80	-1.67	-5.89
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from United States Antimony's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	107,647,317.00	107,647,317.00	108,438,984.00	108,438,984.00	-	229,264,738.00	117,922,971.00	120,723,320.00	140,035,604.00	143,371,936.00	148,185,622.00
DEI Adjusted Shares Outstanding	107,647,317.00	107,647,317.00	108,438,984.00	108,438,984.00	-	229,264,738.00	117,922,971.00	120,723,320.00	140,035,604.00	143,371,936.00	148,185,622.00
DEI Earnings Per Adjusted Shares Outstanding	-0.03	0.00	0.00	-0.01	-	0.00	0.00	-0.04	0.00	-0.08	0.00
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	52.47%	38.95%	61.71%	24.65%	219.08%	127.86%	187.34%	238.31%	-	-3.08%	-24.70%
EBITDA Growth	-985.90%	-149.68%	256.46%	-185.68%	91.52%	273.17%	84.05%	-507.49%	-	-1,859.47%	-15.70%
EBIT Growth	-783.25%	-170.65%	126.66%	-144.93%	81.85%	174.82%	-47.35%	-457.04%	-	-3,375.31%	-1,066.24%
NOPAT Growth	-701.26%	-226.04%	140.55%	-144.97%	81.64%	208.71%	-64.28%	-451.86%	-	-1,569.88%	-34,992.29%
Net Income Growth	-362.85%	60.00%	160.27%	55.76%	75.20%	269.32%	-10.47%	-557.13%	-	-2,166.60%	-39.25%
EPS Growth	-3,225,551,060,700.00%	-100.00%	-100.00%	-100.00%	-0.85%	0.00%	0.00%	-300.00%	-	0.00%	0.00%
Operating Cash Flow Growth	-1,389.49%	107.07%	327.85%	-13.01%	132.96%	-2,759.34%	-210.91%	-1,039.62%	-	-597.38%	-1,279.73%
Free Cash Flow Firm Growth	-44.30%	300.65%	152.32%	353.80%	142.89%	-177.60%	-383.12%	-451.68%	-	-991.64%	-691.67%
Invested Capital Growth	-0.53%	-49.42%	-15.45%	-56.24%	-21.50%	77.13%	52.98%	372.19%	-	410.04%	241.68%
Revenue Q/Q Growth	4.37%	42.65%	19.23%	-29.78%	183.84%	1.87%	50.36%	-17.32%	-	-47.94%	16.83%
EBITDA Q/Q Growth	-2,278.06%	94.23%	145.00%	-563.05%	25.11%	217.80%	-52.17%	-1,628.37%	-	-4,005.14%	102.29%
EBIT Q/Q Growth	-1,860.25%	93.32%	110.74%	-1,840.22%	-52.91%	127.56%	-92.44%	-18,510.54%	-	-1,834.56%	97.77%
NOPAT Q/Q Growth	-1,791.84%	93.16%	117.01%	-1,213.62%	-49.51%	140.48%	-94.41%	-17,304.12%	-	-91.78%	-32.67%
Net Income Q/Q Growth	-116.49%	90.93%	162.83%	-458.75%	-21.36%	161.90%	-66.78%	-2,733.20%	-	-3,836.67%	100.98%
EPS Q/Q Growth	-399.64%	100.00%	0.00%	0.00%	-399.98%	100.00%	0.00%	0.00%	-	0.00%	100.00%
Operating Cash Flow Q/Q Growth	-957.70%	101.60%	770.31%	-27.34%	198.03%	-229.41%	63.70%	-515.54%	-	-247.51%	28.19%
Free Cash Flow Firm Q/Q Growth	-42.45%	256.31%	-63.86%	215.37%	-76.02%	-382.83%	-31.86%	-291.74%	-	-50.92%	4.38%
Invested Capital Q/Q Growth	-15.89%	-41.62%	81.19%	-50.82%	50.88%	31.75%	56.49%	51.79%	-	44.24%	4.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	-203.59%	19.19%	34.13%	16.48%	19.06%	33.88%	26.96%	23.14%	-	16.35%	7.36%
EBITDA Margin	-295.95%	-11.96%	4.51%	-29.77%	-7.86%	9.09%	2.89%	-53.45%	-	-165.04%	3.24%
Operating Margin	-319.52%	-15.31%	1.53%	-34.64%	-18.39%	5.11%	0.19%	-56.51%	-	-110.81%	-88.08%
EBIT Margin	-328.99%	-15.42%	1.39%	-34.42%	-18.71%	5.06%	0.25%	-56.67%	-	-171.09%	-3.27%
Profit (Net Income) Margin	-165.32%	-10.51%	5.54%	-28.28%	-12.85%	7.81%	1.73%	-54.94%	-	-166.49%	1.39%
Tax Burden Percent	70.64%	100.00%	100.00%	100.00%	132.01%	100.00%	100.00%	100.00%	-	100.14%	66.12%
Interest Burden Percent	71.14%	68.15%	398.64%	82.18%	52.02%	154.23%	677.82%	96.95%	-	97.17%	-64.45%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Return on Invested Capital (ROIC)	-142.83%	-8.68%	1.07%	-23.95%	-15.87%	8.78%	0.27%	-62.36%	-	-70.71%	-66.15%
ROIC Less NNEP Spread (ROIC-NNEP)	-151.16%	-8.72%	-0.10%	-23.28%	-15.88%	7.74%	-0.93%	-57.62%	-	-55.41%	-77.83%
Return on Net Nonoperating Assets (RNNOA)	79.45%	5.08%	0.05%	13.32%	8.77%	-4.81%	0.40%	33.58%	-	26.55%	43.26%
Return on Equity (ROE)	-63.38%	-3.60%	1.11%	-10.64%	-7.10%	3.98%	0.67%	-28.78%	-	-44.16%	-22.89%
Cash Return on Invested Capital (CROIC)	-35.82%	18.71%	-17.46%	28.85%	10.28%	-65.62%	-48.04%	-149.58%	-	-161.13%	-143.10%
Operating Return on Assets (OROA)	-91.09%	-4.84%	0.50%	-13.00%	-8.91%	2.83%	0.17%	-32.93%	-	-71.23%	-1.00%
Return on Assets (ROA)	-45.77%	-3.30%	1.98%	-10.68%	-6.12%	4.36%	1.16%	-31.93%	-	-69.32%	0.43%
Return on Common Equity (ROCE)	-63.34%	-3.60%	1.11%	-10.63%	-7.10%	3.98%	0.67%	-28.77%	-	-44.15%	-22.89%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-23.08%	0.00%	0.00%	0.00%	-2.64%	0.00%	0.00%	-	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-4.82	-0.33	0.06	-0.62	-0.88	0.36	0.02	-3.44	-2.74	-5.26	-6.98
NOPAT Margin	-223.66%	-10.72%	1.53%	-24.25%	-12.87%	5.11%	0.19%	-39.55%	-	-77.56%	-88.08%
Net Nonoperating Expense Percent (NNEP)	8.33%	0.04%	1.17%	-0.67%	0.01%	1.05%	1.20%	-4.74%	-	-15.30%	11.67%
Return On Investment Capital (ROIC_SIMPLE)	-18.85%	-1.30%	0.21%	-2.45%	-3.06%	1.09%	0.05%	-4.78%	-1.94%	-3.98%	-3.85%
Cost of Revenue to Revenue	303.59%	80.81%	65.87%	83.52%	80.94%	66.12%	73.04%	76.86%	-	83.65%	92.64%
SG&A Expenses to Revenue	104.86%	33.93%	32.60%	51.75%	44.97%	28.77%	26.77%	85.14%	-	40.52%	42.14%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Operating Expenses to Revenue	36.58%	34.50%	32.60%	51.12%	37.95%	28.77%	26.77%	79.64%	-	127.16%	95.44%
Earnings before Interest and Taxes (EBIT)	-7.09	-0.47	0.05	-0.89	-1.29	0.35	0.03	-4.93	-0.60	-12	-0.26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-6.37	-0.37	0.17	-0.77	-0.54	0.64	0.30	-4.65	-0.27	-11	0.26
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.05	1.06	1.42	3.29	6.71	7.74	6.86	10.43	-	9.49	5.94
Price to Tangible Book Value (P/TBV)	1.05	1.06	1.42	3.29	6.71	7.74	6.86	10.43	-	9.49	5.94
Price to Revenue (P/Rev)	3.08	2.82	3.33	7.22	12.85	13.37	9.99	23.49	-	32.06	29.52
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.10	1.89	1.70	9.93	16.33	16.64	10.99	21.29	-	16.64	12.93
Enterprise Value to Revenue (EV/Rev)	1.71	1.57	2.23	6.12	11.65	12.38	9.39	22.29	-	30.52	26.64
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	78.37	548.49	0.00	0.00	-	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	6.78	0.00	20.95	139.66	0.00	0.00	0.00	-	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.02	0.01	0.01	0.01	0.01	0.00	-	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.01	0.01	0.01	0.01	0.00	0.00	-	0.00	0.00
Financial Leverage	-0.53	-0.58	-0.44	-0.57	-0.55	-0.62	-0.43	-0.58	-	-0.48	-0.56
Leverage Ratio	1.09	1.08	1.08	1.12	1.16	1.16	1.21	1.13	-	1.14	1.09
Compound Leverage Factor	0.78	0.73	4.32	0.92	0.60	1.80	8.20	1.10	-	1.11	-0.70
Debt to Total Capital	0.11%	0.03%	1.50%	1.41%	1.13%	0.90%	0.69%	0.32%	-	0.12%	0.18%
Short-Term Debt to Total Capital	0.11%	0.03%	0.50%	0.51%	0.46%	0.41%	0.36%	0.19%	-	0.10%	0.10%
Long-Term Debt to Total Capital	0.00%	0.00%	1.00%	0.90%	0.68%	0.49%	0.34%	0.13%	-	0.02%	0.09%
Preferred Equity to Total Capital	0.04%	0.04%	0.04%	0.04%	0.03%	0.03%	0.02%	0.01%	-	0.01%	0.01%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Common Equity to Total Capital	99.85%	99.94%	98.46%	98.55%	98.84%	99.07%	99.28%	99.67%	-	99.87%	99.81%
Debt to EBITDA	0.00	0.00	-0.06	-0.05	-0.25	-0.95	-1.54	-0.06	-	-0.01	-0.02
Net Debt to EBITDA	1.99	1.68	1.76	1.72	13.66	59.96	91.16	9.47	-	3.80	6.63
Long-Term Debt to EBITDA	0.00	0.00	-0.04	-0.03	-0.15	-0.52	-0.75	-0.02	-	0.00	-0.01
Debt to NOPAT	-0.01	0.00	-0.07	-0.06	-0.20	-0.27	-0.23	-0.06	-	-0.01	-0.02
Net Debt to NOPAT	2.41	2.16	2.24	2.20	10.72	16.96	13.88	9.75	-	5.26	6.44
Long-Term Debt to NOPAT	0.00	0.00	-0.05	-0.04	-0.12	-0.15	-0.11	-0.02	-	0.00	-0.01
Altman Z-Score	4.32	5.07	5.80	9.63	18.28	21.59	15.03	55.02	-	46.24	67.49
Noncontrolling Interest Sharing Ratio	0.06%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.02%	-	0.01%	0.01%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	15.68	15.46	11.67	6.24	5.16	5.26	2.21	5.08	-	3.62	11.54
Quick Ratio	14.04	14.37	11.03	5.73	4.82	4.39	1.19	3.43	-	0.96	7.94
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4.75	7.42	2.68	8.45	2.04	-5.76	-7.59	-30	-42	-63	-60
Operating Cash Flow to CapEx	-2,119.63%	123.36%	577.44%	0.00%	648.56%	-200.61%	-9.61%	-44.58%	-	-95.87%	-84.64%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.28	0.31	0.36	0.38	0.48	0.56	0.67	0.58	-	0.42	0.31
Accounts Receivable Turnover	12.33	6.92	8.11	10.50	16.77	12.45	13.07	23.69	-	17.41	14.15
Inventory Turnover	8.72	11.23	9.41	9.55	8.72	5.86	5.19	5.00	-	2.34	2.12
Fixed Asset Turnover	0.68	0.94	1.05	1.11	1.13	1.78	1.87	1.78	-	1.30	1.00
Accounts Payable Turnover	22.17	20.51	27.83	14.94	11.46	7.54	6.01	8.63	-	4.73	6.21
Days Sales Outstanding (DSO)	29.59	52.76	45.02	34.75	21.77	29.32	27.93	15.41	-	20.97	25.80
Days Inventory Outstanding (DIO)	41.86	32.51	38.77	38.21	41.87	62.24	70.28	73.06	-	156.04	172.39
Days Payable Outstanding (DPO)	16.46	17.80	13.11	24.44	31.86	48.38	60.77	42.30	-	77.24	58.75
Cash Conversion Cycle (CCC)	55.00	67.47	70.68	48.51	31.78	43.19	37.43	46.17	-	99.77	139.43
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	14	7.93	14	7.06	11	14	22	33	50	72	75
Invested Capital Turnover	0.64	0.81	0.70	0.99	1.23	1.72	1.42	1.58	-	0.91	0.75
Increase / (Decrease) in Invested Capital	-0.07	-7.75	-2.62	-9.08	-2.92	6.11	7.61	26	39	58	53
Enterprise Value (EV)	15	15	24	70	174	234	242	710	-	1,192	971
Market Capitalization	27	27	36	83	192	252	257	748	-	1,252	1,076
Book Value per Share	$0.24	$0.24	$0.24	$0.23	$0.26	$0.28	$0.32	$0.59	$1.01	$0.92	$1.22
Tangible Book Value per Share	$0.24	$0.24	$0.24	$0.23	$0.26	$0.28	$0.32	$0.59	$1.01	$0.92	$1.22
Total Capital	26	25	26	25	29	33	38	72	141	132	181
Total Debt	0.03	0.01	0.39	0.36	0.33	0.30	0.26	0.23	0.20	0.16	0.33
Total Long-Term Debt	0.00	0.00	0.26	0.23	0.20	0.16	0.13	0.09	0.06	0.02	0.16
Net Debt	-12	-12	-12	-13	-18	-19	-16	-38	-91	-60	-105
Capital Expenditures (CapEx)	0.19	0.05	0.10	-0.24	0.21	0.86	6.53	8.67	12	13	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.23	1.14	1.08	-0.26	-1.47	1.41	2.85	5.93	9.63	27	24
Debt-free Net Working Capital (DFNWC)	13	13	13	13	17	20	9.81	26	45	35	70
Net Working Capital (NWC)	13	13	13	13	17	20	9.68	26	45	35	70
Net Nonoperating Expense (NNE)	-1.26	-0.01	-0.15	0.10	-0.00	-0.19	-0.16	1.34	-2.46	6.03	-7.09
Net Nonoperating Obligations (NNO)	-12	-17	-11	-18	-18	-19	-16	-38	-91	-60	-106
Total Depreciation and Amortization (D&A)	0.71	0.11	0.11	0.12	0.75	0.28	0.28	0.28	0.33	0.41	0.52
Debt-free, Cash-free Net Working Capital to Revenue	14.20%	11.97%	9.82%	-2.30%	-9.82%	7.46%	11.06%	18.62%	-	70.03%	66.03%
Debt-free Net Working Capital to Revenue	151.93%	137.19%	123.17%	111.06%	112.49%	107.36%	38.15%	80.58%	-	90.11%	192.53%
Net Working Capital to Revenue	151.60%	137.11%	121.98%	109.91%	111.61%	106.65%	37.62%	80.16%	-	89.75%	192.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($322,555,106.06)	$107,908,306.00	$108,438,984.00	$108,438,984.00	($324,786,274.02)	$0.00	$0.00	($0.04)	$0.00	($0.08)	$0.00
Adjusted Weighted Average Basic Shares Outstanding	107.55M	108.44M	108.44M	108.44M	108.59M	113.70M	118.26M	123.41M	123.64M	141.61M	146.61M
Adjusted Diluted Earnings per Share	($322,555,106.06)	$107,908,306.00	$108,943,126.00	$108,438,984.00	($325,290,416.02)	$0.00	$0.00	($0.04)	$0.00	($0.08)	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	107.55M	108.44M	108.44M	108.44M	108.59M	122.30M	127.22M	123.41M	123.64M	141.61M	151.75M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	108.44M	108.44M	108.44M	114.63M	117.92M	120.72M	140.04M	143.37M	148.19M	149.67M
Normalized Net Operating Profit after Tax (NOPAT)	-4.66	-0.32	0.04	-0.64	-0.85	0.25	0.01	-3.45	-2.70	-5.26	-4.89
Normalized NOPAT Margin	-216.58%	-10.32%	1.07%	-24.69%	-12.41%	3.57%	0.13%	-39.62%	-	-77.58%	-61.66%
Pre Tax Income Margin	-234.03%	-10.51%	5.54%	-28.28%	-9.73%	7.81%	1.73%	-54.94%	-	-166.25%	2.10%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-12.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%
Augmented Payout Ratio	-12.41%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-33.57%	-50.65%

Financials Breakdown Chart

Key Financial Trends

United States Antimony’s financial profile has expanded significantly, but operating performance remains inconsistent. Total assets increased from $32.3 million in Q2 2023 to $190.6 million in Q2 2026, supported by substantial investment in property, plant and equipment and investments. However, the company’s core business has not yet consistently converted that growth into operating profits.

Revenue rose from $2.3 million in Q2 2023 to $3.7 million in Q2 2024 and $10.5 million in Q2 2025, before declining to $7.9 million in Q2 2026. Gross profit followed a similar pattern, reaching $2.8 million in Q2 2025 but falling to just $583,000 in Q2 2026. The latest quarter produced a gross margin of approximately 7.4%, compared with 26.9% in Q2 2025 and 34.1% in Q2 2024.

UAMY reported a $7.0 million operating loss in Q2 2026, although $7.1 million of net other income helped produce a small $110,000 net profit. This means the reported bottom-line profit was largely dependent on non-operating items rather than the company’s core operations. Cash flow also remains a key concern: operating cash flow was negative $8.7 million in Q2 2026, while capital expenditures totaled $10.2 million. The company ended the quarter with $41.4 million of cash and $4.7 million of short-term investments, but financing inflows were a major source of the quarterly $38.9 million increase in cash.

Substantial balance-sheet expansion: Total assets grew to $190.6 million in Q2 2026 from $28.9 million in Q2 2024, reflecting increased investment in production assets and financial investments.
Strong liquidity position: Cash, short-term investments, and the $4.0 million note and lease receivable totaled approximately $50.7 million at June 30, 2026.
Low reported balance-sheet leverage: Total liabilities were $9.6 million compared with $181.0 million of common equity, giving the company a substantial equity cushion.
Recent return to a small net profit: Q2 2026 net income attributable to common shareholders was $108,000, compared with a $11.3 million loss in Q1 2026.
Revenue remains well above 2023 levels: Q2 2026 revenue of $7.9 million was more than three times Q2 2023 revenue of $2.3 million, despite the year-over-year decline from Q2 2025.
Significant capital investment: Capital expenditures exceeded $10 million in both Q1 and Q2 2026. This could support future production and revenue growth, but the return on those investments has not yet been demonstrated.
Investment income provides support: Interest and investment income rose to $426,000 in Q2 2026 from $155,000 in Q2 2024, helping offset operating losses but also increasing reliance on non-core earnings.
Core operations remain deeply unprofitable: The Q2 2026 operating loss was $7.0 million, following operating losses of $7.5 million in Q1 2026, $4.9 million in Q3 2025, and $3.9 million in Q4 2025.
Sharp deterioration in gross margin: Q2 2026 gross profit fell to $583,000 from $2.8 million in Q2 2025, as cost of revenue consumed approximately 92.6% of sales.
Persistent cash burn and potential dilution: Operating cash flow was negative in each quarter from Q2 2025 through Q2 2026, while weighted-average basic shares increased from 108.4 million in Q2 2024 to 146.6 million in Q2 2026.

Overall, UAMY has a much larger asset base and stronger liquidity than it had two years ago, but investors should focus on whether revenue growth, gross margins, and operating cash flow improve. Until the company can generate sustainable profits from its core operations, recent net income and cash growth may remain heavily influenced by financing activity, investment gains, and other non-operating items.

11/12/26 05:06 AM ETAI Generated. May Contain Errors.

United States Antimony Financials - Frequently Asked Questions

According to the most recent income statement we have on file, United States Antimony's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

United States Antimony's net income appears to be on a downward trend, with a most recent value of -$4.34 million in 2025, falling from -$838.53 thousand in 2015. The previous period was -$1.73 million in 2024. Check out United States Antimony's forecast to explore projected trends and price targets.

United States Antimony's total operating income in 2025 was -$8.46 million, based on the following breakdown:

Total Gross Profit: $9.87 million
Total Operating Expenses: $18.33 million

Over the last 10 years, United States Antimony's total revenue changed from $13.11 million in 2015 to $39.26 million in 2025, a change of 199.5%.

In the past 12 quarters, United States Antimony's cash and equivalents has ranged from $3.22 million in Q1 2026 to $41.43 million in Q2 2026, and is currently $41.43 million as of their latest financial filing in Q2 2026.

United States Antimony had total debt of $195.43 thousand at the end of 2025, a 40.4% decrease from 2024, and a 90.4% decrease since 2015.

Over the last 10 years, United States Antimony's book value per share changed from 0.19 in 2015 to 1.01 in 2025, a change of 435.7%.

Related Companies

Financial statements for NYSE:UAMY last updated on 8/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

United States Antimony (UAMY) Financials

Financials Breakdown Chart

Key Financial Trends

United States Antimony Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

United States Antimony (UAMY) Financials

Annual Income Statements for United States Antimony

Quarterly Income Statements for United States Antimony

Annual Cash Flow Statements for United States Antimony

Quarterly Cash Flow Statements for United States Antimony

Annual Balance Sheets for United States Antimony

Quarterly Balance Sheets for United States Antimony

Annual Metrics And Ratios for United States Antimony

Quarterly Metrics And Ratios for United States Antimony

Financials Breakdown Chart

Key Financial Trends

United States Antimony Financials - Frequently Asked Questions

When does United States Antimony's financial year end?

How has United States Antimony's net income changed over the last 10 years?

What is United States Antimony's operating income?

How has United States Antimony's revenue changed over the last 10 years?

How much cash does United States Antimony have?

How much debt does United States Antimony have?

How has United States Antimony's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools